| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.06 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.087 | 0.07 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.053 | 0.07 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.07 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.085 | 0.07 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.068 | 0.07 |